Dan Chambers

Professor Dan Chambers is the Mayne Chair and Head of the Mayne Academy of Medicine at the University of Queensland. His academic roles include leadership in clinical and translational research focused on lung transplantation, interstitial lung diseases, and pulmonary fibrosis. He holds a faculty position within the Department of Medicine, contributing to both research and clinical education.

Research interests span lung transplantation outcomes, chronic allograft dysfunction, stem cell therapies for fibrosis, immunological mechanisms in transplant rejection, and skin cancer management in organ transplant recipients. His work integrates genomic, immunological, and clinical approaches to improve patient care.

Recent articles highlight advancements in understanding molecular biomarkers for chronic graft dysfunction, transcriptomic changes in alveolar macrophages, and strategies to prevent post-transplant malignancies. Collaborations with international societies like the International Society for Heart and Lung Transplantation (ISHLT) underscore his global influence in the field.

Advances in his research include trials for novel therapies (e.g., sirolimus for skin cancer prevention) and diagnostic protocols for interstitial lung diseases. His contributions are widely recognized through high-impact publications in journals like The Lancet Respiratory Medicine and Journal of Heart and Lung Transplantation.